How Oncotarget Completes Its Mission To Making Scientific Results Quickly and Widely Available

The peer-reviewed scientific journal Oncotarget was first published in 2010. The journal, which is published on a weekly basis, was founded by two professors and cancer researchers, Dr. Mikhail Blagosklonny and Dr. Andrei V. Gudkov. Serving also as co-editors-in-chief, they had established Oncotarget in order to be an outlet for research in the field of Oncology.

Oncotarget has been a very successful publication. The research articles that have been published in it have been cited many times by other researchers. One of the recent papers published in Oncotarget was an influential one which described some of the dangers that come about from smoking e-cigarettes. Many of research papers that are published in Oncotarget are on the cutting edge of medical research just like that paper was. Visit his profile on Google Scholar.

As an open access medical journal, anyone can read Oncotarget’s weekly publications. Being open access is another way that Oncotarget completes its mission to making scientific results widely and quickly available so that science progresses. Oncotarget is dedicated to doing its part to provide a future where people live free of disease.

Since the paper was founded Oncotarget has also established a goal of breaking down the traditional divisions between different fields of biomedical science. To this end, Oncotarget has been expanded to other fields of medicine outside that of Oncology. This publication no accepts research papers from a broad variety of medical specializations such as Cardiology, Metabolism, Immunology, Microbiology, Pharmacology, Neuroscience, and more.

In addition to Dr. Blagosklonny and Dr. Gudkov, Oncotarget has a large number of doctors and researchers that makes up its editorial board. The board members come from a number of different universities and hospital across the United States as well as some located in Europe. Some of the prominent organizations that these professionals work for include Columbia University, Children’s Hospital of Pittsburg, Vanderbilt-Ingram Cancer Center, the University of Rome, and John Hopkins University.

Follow: https://twitter.com/oncotargetjrnl?lang=en